<?xml version="1.0" encoding="UTF-8"?>
<Label drug="tussionex" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  Gastrointestinal Disorders

  Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients. Prolonged administration of TUSSIONEX Pennkinetic Extended-Release Suspension may produce constipation.



   General Disorders and Administration Site Conditions

  Death



   Nervous System Disorders

  Sedation, drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, euphoria, dizziness, psychic dependence, mood changes.



   Renal and Urinary Disorders

  Ureteral spasm, spasm of vesical sphincters, and urinary retention have been reported with opiates.



   Respiratory, Thoracic and Mediastinal Disorders

  Dryness of the pharynx, occasional tightness of the chest, and respiratory depression (see  CONTRAINDICATIONS  ).



 TUSSIONEX Pennkinetic Extended-Release Suspension may produce dose-related respiratory depression by acting directly on brain stem respiratory centers (see  OVERDOSAGE  ). Use of TUSSIONEX Pennkinetic Extended-Release Suspension in children less than 6 years of age has been associated with fatal respiratory depression. Overdose with TUSSIONEX Pennkinetic Extended-Release Suspension in children 6 years of age and older, in adolescents, and in adults has been associated with fatal respiratory depression.



   Skin and Subcutaneous Tissue Disorders

  Rash, pruritus.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
